Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Performance of the Tear Substitute MAF-1217 in Patients With Evaporative DED

NCT03833882 is registered in ClinicalTrials.gov with VISUfarma SpA as lead sponsor.

NCT NCT03833882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03833882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Performance of the Tear Substitute MAF-1217 in Patients With Evaporative DED
Lead sponsor
VISUfarma SpA
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2018
Completion date
June 19, 2019
Enrollment
72 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

evaporative dry eye disease